Novo CEO pressed by Senate to chop selling prices of being overweight, diabetic issues medicines CEO Lars Fruergaard Jørgensen explained to lawmakers the business would contemplate new talks with insurers with regard to the list costs of Wegovy and copyright whenever they pledge to keep the medicines on their own https://kethek.com/